Chemical Economic, M&A and Financing (ICIS Chemical Business November 19-26 2021)
Comprehensive look at the economic, stock market, M&A and financing trends and outlook
Pharm Exec: Doubling Down On Innovation, Recovery (Young & Partners article – September 2021)
While activity and outputs have been mixed, and pandemic challenges linger on, the outlooks for pharma and biotech remain stable
Mixed outlook for chemical financing (ICIS Chemical Business August 27, 2021)
Young & Partners documents slower, but still healthy debt and equity issuance
Chemical M&A market in transition (ICIS Chemical Business August 20, 2021)
Slow M&A market begins to pick up, but with many underlying changes
Pharm Exec: Pharma and Biotech’s 2020 Full-Year View (Young & Partners article – March 2021)
Examines the key biopharma stock numbers and industry trends from a year that challenged like never before
Chemical Industry Financings in 2020 and Outlook (ICIS Chemical Business February 26, 2021)
Chemical debt and equity financing surged due to the pandemic, but outlook still healthy
Chemical M&A – Yearend Summary and Forecast (ICIS Chemical Business, Feb 12, 2021 issue)
After slower M&A market in 2020, Young & Partners forecasts a recovery
Press Release: Société de Chimie Industrielle Elects Peter Young as President (December 10, 2020)
Leading Chemicals and Life Science industry association elects new officers for 2021
Pharma Exec – Taking Pharma’s Pulse in a Tough 2020 (Young & Partners article Sept 2020)
Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead
Debt and Equity Markets Buoyant (ICIS Chemical Business September 4 2020)
Data shows a strong debt market and solid equity issuance, but IPOs all Asian